20 September 2022

Fluorescent ligands: A New Method to Label your GPCRs

To date, it has been reported that about 800 GPCRs are encoded by the human genome. Some of them have known ligands available which led to the […]
26 July 2022

Celtarys Adenosine Receptor fluorescent ligands as potent tools for the study of cancer specific GPCRs

The ONCOMET group from the Health Research Institute of Santiago led by Dr. Miguel Abal has published an interesting article showing tumor and stromal-specific genetic signatures […]
15 July 2022

Celtarys Research and Chemspace sign a distribution agreement for the commercialization of Celtarys products

We are proud to announce our new collaboration with the marketplace company Chemspace for the distribution of our exclusive GPCR fluorescent probes. Chemspace is the largest […]
6 April 2022

New GLP1 Receptor fluorescent probes LUXendins developed by our collaborators Johannes Broichhagen and David J. Hodson

The glucagon-like peptide-1 receptor (GLP1R), expressed in peripheral tissues and brain, is known to be involved in several metabolic and inflammatory processes. Despite its clear interest […]
21 February 2022

Celtarys Research attends the SLAS meeting at Boston and is selected as finalist for the Ignite Award

From February 5th to 9th  our CEO Sonia Martínez Arca has attended the international SLAS,  (Society for Laboratory Automation and Screening), meeting at Boston.  Celtarys Research […]
3 February 2022

Celtarys Research Adenosine A3 Receptor fluorescent ligand as a new tool for the study of non-orthosteric interactions

The group led by Dr. Eddy Sotelo at the University of Santiago de Compostela, in collaboration with the Uppsala University, has published a new article exploring […]
28 December 2021

Celtarys exclusive fluorescent ligands for cannabinoid receptors used to analyze binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors

Don’t miss the new article by Dr. Gemma Navarro and Dr. Rafael Franco about cannabinoid CB1 and CB2 receptors signaling. They have successfully used CELT-335, one […]
21 December 2021

Celtarys Research awarded as “Best Business Idea” by the Galician Biotechnology Cluster Bioga

Last December 16th the Galician Biotechnology Cluster Bioga announced the winners of the 9th edition of their annual Bioga Awards, which represent a recognition of the […]
24 November 2021

Celtarys Research has participated in a round table focused on new trends in oncology at Farmaforum 21

Farmaforum has become one of the most important events of the pharmaceutical industry in Spain. In the 2021 edition, it has extended its scope, sharing synergies […]